Paul G. Allen Frontiers Group    [to 23 May 2020]
News from The Paul G. Allen Frontiers Group: May 2020
May 20, 2020
Highlights include an important message for our research community, a face mask that detects coronavirus, our new video series #ScienceMatters, and more.
BARDA   [to 23 May 2020]
BARDA News​​
May 21, 2020: Trump Administration’s Operation Warp Speed Accelerates AstraZeneca COVID-19 Vaccine to be Available Beginning in October
May 19, 2020: HHS, Industry Partners Expand U.S.-Based Pharmaceutical Manufacturing for COVID-19 Response
BMGF – Gates Foundation  [to 23 May 2020]
MAY 21, 2020
Bill & Melinda Gates Foundation Appoints Three New Members to Executive Leadership Team
SEATTLE, May 21, 2020 – Today the Bill & Melinda Gates Foundation named three new members to its Executive Leadership Team (ELT). Ankur Vora will become Chief Strategy Officer, Gargee Ghosh will become President, Global Policy & Advocacy, and Susan Byrnes will become Chief Communications Officer. Each will assume their new roles effective June 1, 2020.
Bill & Melinda Gates Medical Research Institute    [to 23 May 2020]
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.
CARB-X   [to 23 May 2020]
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
CARB-X funds Facile Therapeutics to develop a new treatment to prevent recurring C. difficile bacterial infections
CARB-X is awarding Facile Therapeutics, based in Belmont, California, USA, up to $1.26 million to develop a new orally bioavailable drug to treat recurring infections caused by Clostridium difficile. Facile could receive up to $17 million more in additional funding from CARB-X if the project achieves certain development milestones, for a potential total of $18.26 million.
CEPI – Coalition for Epidemic Preparedness Innovations  [to 23 May 2020]
Latest News
No new digest content identified.
Clinton Health Access Initiative, Inc. (CHAI)  [to 23 May 2020]
News & Press Releases
No new digest content identified.
EDCTP    [to 23 May 2020]
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
Latest news
18 May 2020
World HIV Vaccine Day 2020
Emory Vaccine Center    [to 23 May 2020]
No new digest content identified.
European Medicines Agency  [to 23 May 2020]
News & Press Releases
Press release: Global regulators commit to cooperate on observational research in the context of COVID-19
Last updated: 20/05/2020
News: Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19 – update #2
Last updated: 18/05/2020
European Vaccine Initiative  [to 23 May 2020]
Latest News
No new digest content identified.
FDA [to 23 May 2020]
Press Announcements
May 22, 2020 – Coronavirus (COVID-19) Update: Daily Roundup May 22, 2020
May 21, 2020 – Coronavirus (COVID-19) Update: Daily Roundup May 21, 2020
May 21, 2020 – Coronavirus (COVID-19) Update: FDA Provides Promised Transparency for Antibody Tests
May 20, 2020 – Coronavirus (COVID-19) Update: Daily Roundup May 20, 2020
May 19, 2020 – USDA, FDA Strengthen U.S. Food Supply Chain Protections
May 19, 2020 – Coronavirus (COVID-19) Update: Daily Roundup May 19, 2020
May 19, 2020 – Coronavirus (COVID-19) Update: FDA Collaborations Promote Rigorous Analyses of Real-World Data to Inform Pandemic Response

Today, we are announcing another step in our effort to harness diverse streams of data to understand and respond to COVID-19. The U.S. Food and Drug Administration has entered into an agreement with Aetion to collaborate on advanced analytical techniques to answer urgent coronavirus disease (COVID-19) research questions. The FDA and Aetion aim to answer questions about the use of diagnostics and medications in the pandemic, and risk factors for COVID-19-related complications in different patient populations. We believe that this work has the potential to contribute to the scientific evaluation of potential diagnostics and interventions for COVID-19…
May 18, 2020 – Coronavirus (COVID-19) Update: Daily Roundup May 18, 2020
Fondation Merieux  [to 23 May 2020]
News, Events
No new digest content identified.
Gavi [to 23 May 2020]
News releases
Virtual Conference
4 June 2020
The UK government will host Gavi’s third donor pledging conference to mobilise at least US$ 7.4 billion in additional resources to protect the next generation with vaccines, reduce disease inequality and create a healthier, safer and more prosperous world.
22 May 2020
At least 80 million children at risk of disease as COVID-19 disrupts vaccination efforts, warn Gavi, WHO and UNICEF
[See Milestones above]
GHIT Fund   [to 23 May 2020]
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that No new digest content identified.
Global Fund  [to 23 May 2020]
Sourcing & Management of Health Products
During COVID-19, HIV Medication in Ukraine Arrives by Post
19 May 2020
Building Resilient and Sustainable Systems for Health
19 May 2020
Resources for Community-Based Monitoring
18 May 2020
Hilleman Laboratories   [to 23 May 2020]
No new digest content identified.
Human Vaccines Project   [to 23 May 2020]
No new digest content identified.
IAVI  [to 23 May 2020]
Press Releases
No new digest content identified.
International Coalition of Medicines Regulatory Authorities [ICMRA]
Selected Statements, Press Releases, Research
No new digest content identified.
International Generic and Biosimilar Medicines Association [IGBA]
No new digest content identified.
Press Releases
No new digest content identified.
IFRC   [to 23 May 2020]
Selected Press Releases, Announcements
Africa, Burundi, Ethiopia, Kenya, Rwanda, South Sudan, Tanzania, Uganda
East Africa: Red Cross raises the alarm over a “triple menace” of floods, COVID-19 and locusts
Nairobi/Geneva, 20 May 2020—A series of mutually exacerbating disasters is unfolding in East Africa, on a scale rarely seen in decades, warned the International Federation of Red Cross and Red Crescent Societies (IFRC). Ongoing heavy rain—which has kil …
20 May 2020
IVAC  [to 23 May 2020]
No new digest content identified.
IVI   [to 23 May 2020]
Selected IVI News & Announcements
IVI to strengthen COVID-19 surveillance in sub-Saharan Africa with support from Sweden
  IVI will leverage its network of infectious disease surveillance sites to conduct epidemiological studies of COVID-19 in Madagascar and Burkina Faso
   Sida’s contribution will significantly build in-country capacity to proactively respond to the pandemic
May 21, 2020 – SEOUL, South Korea – The International Vaccine Institute (IVI) announced today that the Swedish International Development Cooperation Agency (Sida) has contributed an additional 6,200,000 SEK (approx. 630,000 USD) to IVI to support national responses to COVID-19 in Madagascar and Burkina Faso…
JEE Alliance  [to 23 May 2020]
Selected News and Events
No new digest content identified.
MSF/Médecins Sans Frontières  [to 23 May 2020]
Latest [Selected Announcements]
MSF statement on inquiry in Borno, Nigeria
Statement 22 May 2020
Médecins Sans Frontières (MSF) has taken note of the first public communication from the Committee set up by the Governor of Borno state, Nigeria, regarding the inquiry into the COVID-19 index case…
Catastrophe unfolding in Aden’s only COVID-19 treatment centre
Press Release 21 May 2020
South Sudan
Renewed violence in Pieri kills and wounds dozens, including MSF staff
Press Release 19 May 2020
Coronavirus COVID-19 pandemic
MSF opens a COVID-19 treatment centre in Haiti
Project Update 18 May 2020
Coronavirus COVID-19 pandemic
Five things we can do to protect people on the move during COVID-19
Project Update 18 May 2020
National Vaccine Program Office – U.S. HHS  [to 23 May 2020]
NVAC 2020 Meetings
June 9-10, 2020 NVAC Meeting
September 23-24, 2020 Meeting (Virtual)
NIH  [to 23 May 2020]
Selected News Releases
Peer-reviewed data shows remdesivir for COVID-19 improves time to recovery
May 22, 2020 — Preliminary results from NIH clinical trial published.
NIH-funded study to investigate pregnancy outcomes resulting from COVID-19 pandemic
May 19, 2020 — Researchers to evaluate medical records of 21,000 pregnant women
NIH Director: Defeating COVID-19 requires unprecedented action and collaboration
May 18, 2020 — ever has a public-private biomedical research effort of this scope and scale come together with such speed and determination. Viewpoint published today in JAMA
[See Milestones above for detail]
PATH  [to 23 May 2020]
Selected Announcements
PATH and partners coordinate COVID-19 global respiratory care response
Seattle, WA, May 20, 2020 – PATH and a coalition of partners will support low- and middle-income countries (LMICs) in the development and execution of a comprehensive respiratory care plan to respond to COVID-19. The initiative will also pursue strategies to help prioritize and improve access to oxygen therapy and other essential equipment involved in respiratory care as an integral part of health systems strengthening, beyond the pandemic response.
Studies have shown that approximately 41 percent of confirmed COVID-19 patients—and in severe cases, more than 60 percent—received oxygen therapy to support breathing. In many health facilities across LMICs, oxygen therapy—including diagnosis, generation, and delivery equipment—is not reliably available, and, without careful planning and coordination, the rapid deployment of COVID-19 resources can quickly overwhelm existing health care systems.
A primary goal of the initiative is to coordinate tools, resources, and capabilities to ensure that those who need respiratory care due to COVID-19, or beyond, receive it. Immediate steps in that strategy will include supporting rapid respiratory care capacity assessments, supplier landscaping and outreach, global respiratory care response coordination, and informed decision-making on procurement and use of respiratory care products…
Sabin Vaccine Institute  [to 23 May 2020]
Statements and Press Releases
No new digest content identified.
UNAIDS [to 23 May 2020]
Selected Press Releases/Reports/Statements
22 May 2020
UNAIDS and civil society helping stranded people living with HIV
21 May 2020
Mapping community responses to COVID-19 and HIV in eastern Europe and central Asia
21 May 2020
Communities strengthening the AIDS response in Nepal
20 May 2020
Kenyan sex workers abandoned and vulnerable during COVID-19
19 May 2020
The high possible cost of COVID-19 on new HIV infections among children
19 May 2020
Gender-based violence and COVID-19—“When we are silent, we allow these crimes to multiply”
UNICEF  [to 23 May 2020]
Selected Press releases/Announcements
Remarks by Henrietta Fore UNICEF Executive Director at joint press briefing on immunization with WHO and Gavi, 22 May
Press release
At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupts routine vaccination efforts, warn Gavi, WHO and UNICEF
Agencies call for joint effort to safely deliver routine immunization and proceed with vaccination campaigns against deadly vaccine-preventable diseases.
Press release
Surge in violent attacks during COVID-19 lockdown puts children’s lives at risk in eastern Ukraine
UN Children’s Agency calls for all parties to the conflict to join global ceasefire and end more than six years of fighting
Press release
COVID-19: Dangers mount for migrant children forcibly returned to northern Central America and Mexico during pandemic
Virus fears compound existing discrimination and violence for returned migrant children, leaving them doubly at risk, UNICEF warns
Press release
At least 19 million children at imminent risk as Cyclone Amphan makes landfall in Bangladesh and India
Cyclone and COVID-19 present dual threats to children and families in the region, warns UNICEF
Press release
UNICEF and Airtel Africa announce partnership to support children and families affected by COVID-19
As millions of children are affected by school closures due to COVID-19, Airtel Africa will help provide access to online learning and better enable cash transfers for children and their families in sub-Saharan Africa
Press release
Escalating violence in eastern DRC is straining humanitarian assistance to women and children
Press release
Over quarter of a million children in Libya are at risk from vaccine-preventable diseases
Joint UNICEF & WHO Press Release
Unitaid  [to 23 May 2020]
Featured News
20 May 2020
World Health Assembly puts multilateral cooperation and equity at heart of COVID-19 response
Unitaid welcomes the adoption of a key Resolution by the World Health Assembly that sets out its response to the COVID-19 pandemic, that places multilateral cooperation and equity at its heart.
The Resolution calls for universal, timely and equitable access to and fair distribution of all quality, safe, efficacious and affordable essential health technologies and products as a global priority.
In particular Unitaid notes the call for collaboration to develop, test, and scale-up production of safe, effective, quality, affordable diagnostics, therapeutics, medicines and vaccines for the COVID-19 response, including, existing mechanisms for voluntary pooling and licensing of patents to facilitate timely, equitable and affordable access.
Speaking after the adoption of the Resolution, Dr Philippe Duneton, Unitaid Executive Director a.i. said, “Unitaid is committed to working with its partners in the Access to COVID-19 Tools Accelerator initiative to ensure that innovations to detect, treat and prevent COVID-19 are adapted and available to the most vulnerable populations.”
He continues, “As highlighted in the Resolution, Unitaid encourages all partners to take advantage of existing mechanisms for voluntary pooling and licensing of intellectual property rights for these global public goods, in particular the Medicines Patent Pool. We also recognise the importance of involving civil society and communities in shaping and delivering the response.”
For the text of Resolution A73/CONF./1 Rev.1, adopted on 19 May 2020, please see here.
Vaccination Acceptance Research Network (VARN)  [to 23 May 2020]
No new digest content identified.
Vaccine Confidence Project  [to 23 May 2020]
Latest News & Archive
Child Vaccinations Plummet 63 Percent, a New Hurdle for New York City Schools
23 May 2020
Vaccine Education Center – Children’s Hospital of Philadelphia  [to 23 May 2020]
No new digest content identified.
Wellcome Trust  [to 23 May 2020]
Opinion | 21 May 2020
Open access: how COVID-19 will change the way research findings are shared
Robert Kiley, Head of Open Research Wellcome
During the COVID-19 pandemic, researchers and publishers have pulled together to publish their outputs at an unprecedented rate. So, how have they responded? And how will this change research culture and the way findings are disseminated in future?
The Wistar Institute   [to 23 May 2020]
Press Releases
May. 20, 2020
Positive Results from Preclinical Testing Support Clinical Development 
of COVID-19 DNA Vaccine
PHILADELPHIA — (May 20, 2020) — The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious disease, announces a study reporting initial immunogenicity of a synthetic DNA vaccine for SARS-CoV-2 developed in collaboration with Inovio Pharmaceutical, Inc., and other scientists. Published in Nature Communications, the report focuses on immune studies in animals, which show induction of functional antibody responses and T-cell responses following immunization. The vaccine, INO-4800, was advanced to phase 1 clinical testing in 10 weeks ( NCT04336410).
WFPHA: World Federation of Public Health Associations  [to 23 May 2020]
Latest News
No new digest content identified.
World Organisation for Animal Health (OIE)   [to 23 May 2020]
Press Releases
No new digest content identified.
ARM [Alliance for Regenerative Medicine]  [to 23 May 2020]
Press Releases
No new digest content identified.
BIO    [to 23 May 2020]
Press Releases
No new digest content identified.
DCVMN – Developing Country Vaccine Manufacturers Network  [to 23 May 2020]
Webinar: A breakthrough high-performance viral vaccines bio-manufacturing platform to countermeasure epidemic threats
26 May 2020
IFPMA   [to 23 May 2020]
Selected Press Releases, Statements, Publications
Pharma and other innovative health groups tell World Health Assembly it stands united with governments
Geneva, May 19, 2020: At the Seventy-Third World Health Assembly, IFPMA, the industry body representing the innovative biopharmaceutical industry delivered a joint statement on behalf of the global interests of broad innovative health industries, reasserting that they stand united with governments and global health stakeholders worldwide to combat COVID-19. The biopharmaceutical industry is joined by biotech, self-medication, diagnostic, and medical technology industries committed to the goal of accelerating development, production and equitable global access to safe, quality, effective, and affordable COVID-19 medical products and to ensure that in the fight against COVID-19, no one is left behind.
According to BioCentury, there are nearly 400 potential treatments and vaccines for COVID-19 in development. Much of the current COVID-19 R&D that has been deployed at an unprecedented speed is built upon products, expertise and research capacity that has been refined and developed by the private sector over many years and thanks to an ecosystem that    supports innovation, which is underpinned by solid intellectual property rights.
Thomas Cueni, Director General of the IFPMA said: “We understand accelerated development and production of new COVID-19 tools is not enough: we must also ensure equitable global access to safe, quality, effective, and affordable COVID-19 diagnostics, therapeutics and vaccines – making sure no-one is left behind. Biopharmaceutical companies have publicly committed to, and are actively working with, governments, insurers, foundations and international organizations to make future COVID-19 products available and affordable to those that need them”…
Joint Statement – Innovative Health Industries @ WHA73
Published on: 18 May 2020
This Statement is made by the International Federation of Pharmaceutical Manufacturers and Associations, the Global Diagnostic Imaging, Healthcare IT & Radiation Therapy Trade Association, the Global Self-Care Federation, the Global Medical Technology Alliance, and the International Council of Biotechnology Associations.
Our organizations believe that coordinated, inclusive, and multi-stakeholder action is the only possible solution to mitigate the impact of this unprecedented global health emergency, and believe the private sector must be an equal partner in coordination efforts. As WHO’s Director General has recently stated, “the private sector has an essential role to play in combating this public health crisis through their expertise, innovation, and resources.”…
ICBA – International Council of Biotechnology Associations   [to 23 May 2020]
ICBA Joins Innovative Health Industries Network Statement on COVID-19 Ahead of World Health Assembly
May. 18 2020
PhRMA    [to 23 May 2020]
Selected Press Releases, Statements
Clinical Trials Awareness Week: Recognizing unsung heroes in medical research
Richard Moscicki, M.D.   |     May 18, 2020
This week is Clinical Trials Awareness Week — an event to recognize the importance of clinical trials, raise public awareness of clinical research and honor clinical research professionals and importantly, volunteer participants for their roles in helping to develop safe and effective medicines.
The biopharmaceutical industry sponsors thousands of clinical trials each year to assess the safety and efficacy of medicines, vaccines and other therapies. Instrumental to these carefully designed studies is patient participation. According to most recent data, industry-sponsored clinical trials engage over 920,000 volunteers yearly to assess effectiveness for devastating conditions, like Alzheimer’s disease, rare diseases and cancers…
Industry Watch   [to 23 May 2020]
:: Sinovac Secures $15 Million in Funding to Accelerate COVID-19 Vaccine Development
May 22, 2020
Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced a transaction in which Advantech Capital and Vivo Capital ha…
:: Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
May 18, 2020
Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, toda…